ALDEYRA THERAPEUTICS INC (ALDX)

US01438T1060 - Common Stock

4.7  -0.07 (-1.47%)

After market: 4.7 0 (0%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
49.64M42.79M62.68M56.22M34.67M
Research and Development
37.89M29.46M47.31M44.94M24.68M
Selling, General, and Administrative Expenses
11.74M13.34M15.37M11.28M9.99M
Operating Income
-49.64M-42.79M-62.68M-56.22M-34.67M
Interest Income/Expense
4.84M5.25M660.00K-1.56M-1.61M
Non Recurring Items
N/AN/AN/A0.00-1.75M
Income Before Taxes
-44.80M-37.54M-62.02M-57.78M-38.03M
Income Tax
N/AN/AN/A0.00-480.00K
Net Income
-44.80M-37.54M-62.02M-57.78M-37.55M
EBITDA
-49.39M-42.53M-62.42M-55.96M-34.61M
 
Per Share Data
EPS Diluted Total Ops
-0.75-0.64-1.06-1.07-1.11
Non GAAP EPS
-0.75-0.64-1.06-1.07-1.12
 
Statistics

All data in USD

Charts